NCT05411913

Brief Summary

Various OTC and CBD containing topicals are evaluated in a double blind survey. Each sample has a QR code that is to be scanned before applying. The QR code links to a survey form with application instructions and collects participant information and feedback.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for phase_3 pain

Timeline
Completed

Started Jul 2022

Shorter than P25 for phase_3 pain

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2022

Completed
Last Updated

June 9, 2022

Status Verified

June 1, 2022

Enrollment Period

4 months

First QC Date

June 2, 2022

Last Update Submit

June 6, 2022

Conditions

Pain

Outcome Measures

Primary Outcomes (1)

  • Pain Before/After Application

    McGill Pain Questionnaire

    5 min post intervention

Secondary Outcomes (1)

  • Efficiency

    5 min post intervention

Interventions

GoodFOR PainDRUG

GoodFOR Pain is a FDA registered topical analgesic.

Icy HotDRUG

a FDA OTC registered topical analgesic.

Tiger BalmDRUG

a FDA OTC registered topical analgesic

BengayDRUG

a FDA OTC registered topical analgesic.

CBD Clinic Muscle and Joint Pain Relief OintmentDRUG

a non FDA registered topical analgesic.

CBD FX CBD Muscle and Joint Cream: Cooling FormulaDRUG

a non FDA registered topical analgesic.

Essential Wholesale Muscle GelDRUG

a non FDA registered topical analgesic.

Extract Labs Muscle CreamDRUG

a non FDA registered topical analgesic.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • has Pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Interventions

methyl salicylateMenthol

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsCyclohexane MonoterpenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsMonoterpenesTerpenesLipids

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Everything is masked by QR code - participant and intervention
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Individuals are provided with a sample of topical substance to apply to a localized region of pain.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Scientist

Study Record Dates

First Submitted

June 2, 2022

First Posted

June 9, 2022

Study Start

July 1, 2022

Primary Completion

October 31, 2022

Study Completion

November 25, 2022

Last Updated

June 9, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share